Targeting tau degradation: a viable therapeutic approach? Mason M, Bacioglu M, Vivacqua G, Spillantini MG, et al. Lancet Neurol 2023;22:462-464.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mason M, Bacioglu M, Vivacqua G, Spillantini MG, et al. Targeting tau degradation: a viable therapeutic approach? Lancet Neurol 2023;22:462-464.
PMID: 37030317